Search

  • HOME
  • Search
Review
1692
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
Clin Mol Hepatol. 2022;28(3):425-472.   Published online July 1, 2022
View: 2575   Download: 184  Citation: 1
Guideline
KASL clinical practice guidelines for management of chronic hepatitis B
Clin Mol Hepatol. 2022;28(2):276-331.   Published online April 1, 2022
View: 4777   Download: 347  Citations: 5
1619
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
Clin Mol Hepatol. 2021;27(3):363-401.   Published online June 22, 2021
View: 10517   Download: 996  Citations: 50
Review
1569
Recent updates on the management of autoimmune hepatitis
Atsumasa Komori
Clin Mol Hepatol. 2021;27(1):58-69.   Published online December 10, 2020
View: 7273   Download: 658  Citations: 14
Original Article
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol. 2020;26(4):516-528.   Published online September 11, 2020
View: 3696   Download: 166  Citations: 24
Review
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung-Soo Kim, Byung-Wan Lee
Clin Mol Hepatol. 2020;26(4):430-443.   Published online August 14, 2020
View: 5924   Download: 371  Citations: 18
1499
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol. 2020;26(3):251-260.   Published online March 19, 2020
View: 12376   Download: 357  Citations: 31
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
Tommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Clin Mol Hepatol. 2019;25(4):360-365.   Published online May 2, 2019
View: 4102   Download: 241  Citations: 8
Original Article
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol. 2017;23(2):160-169.   Published online May 16, 2017
View: 6836   Download: 212  Citations: 19
1327
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol. 2016;22(4):458-465.   Published online December 25, 2016
View: 7368   Download: 128  Citations: 6
Review
1323
Acute kidney injury in liver cirrhosis: new definition and application
Florence Wong
Clin Mol Hepatol. 2016;22(4):415-422.   Published online December 14, 2016
View: 12096   Download: 734  Citations: 42
Case Report
A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy
Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song
Clin Mol Hepatol. 2016;22(3):396-399.   Published online August 30, 2016
View: 15464   Download: 110  Citations: 8
Original Article
1317
Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Clin Mol Hepatol. 2016;22(3):382-389.   Published online September 25, 2016
View: 10451   Download: 188  Citations: 19
1312
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol. 2016;22(3):339-349.   Published online September 25, 2016
View: 9779   Download: 154  Citations: 15
Review
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen
Clin Mol Hepatol. 2016;22(3):327-335.   Published online September 25, 2016
View: 13342   Download: 524  Citations: 46
Editorial
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clin Mol Hepatol. 2016;22(2):238-240.   Published online June 25, 2016
View: 6885   Download: 88  Citation: 1
Review
KASL clinical practice guidelines: Management of Hepatitis C
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol. 2014;20(2):89-136.   Published online June 30, 2014
View: 22654   Download: 79  Citations: 29
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
Hyung Joon Yim, Seong Gyu Hwang
Clin Mol Hepatol. 2013;19(3):195-209.   Published online September 30, 2013
View: 9940   Download: 63  Citations: 23
Original Article
Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6
Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim
Clin Mol Hepatol. 2013;19(1):45-50.   Published online March 25, 2013
View: 6290   Download: 77  Citations: 12
Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clin Mol Hepatol. 2012;18(2):195-202.   Published online June 26, 2012
View: 7631   Download: 65  Citations: 11
High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B
Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn
Clin Mol Hepatol. 2012;18(1):75-83.   Published online March 22, 2012
View: 5934   Download: 42  Citations: 12
Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience
Sang Seok Lee, Hyun Sung Shin, Hyung Joon Kim, Su Jin Lee, Hyun Suk Lee, Kyung Hee Hyun, Yong Hyun Kim, Byoung Woon Kwon, Jin Hyung Han, Hoon Choi, Bae Hwan Kim, Joon Hyuk Lee, Ha Yan Kang, Hyun Deok Shin, Il Han Song
Clin Mol Hepatol. 2012;18(1):48-55.   Published online March 22, 2012
View: 6419   Download: 48  Citations: 32
Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center
Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh
Clin Mol Hepatol. 2011;17(2):113-119.   Published online June 23, 2011
View: 6987   Download: 41  Citations: 21
Review
New treatments for chronic hepatitis C
Jae Young Jang, Raymond T. Chung
Clin Mol Hepatol. 2010;16(3):263-277.   Published online September 30, 2010
View: 6385   Download: 42  Citations: 14
3
Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b
Young-Joo Jin, M.D., Yoon Kyung Park, M.D., Gui Jun Yun, M.D. Han Chu Lee, M.D., Sook-Hyang Jeong, M.D. Gang Mo Kim, M.D., Young-Suk Lim, M.D., Young-Hwa Chung, M.D., Yung Sang Lee, M.D., Dong Jin Suh, M.D.
Clin Mol Hepatol. 2010;16(2):158-167.   Published online June 25, 2010
View: 3549   Download: 20
Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B
Hyung-Joon Myung, M.D., Sook-Hyang Jeong, M.D., Jin-Wook Kim, M.D., Hee-Sup Kim, M.D., Je-Hyuck Jang, M.D., Dong Ho Lee, M.D., Nayoung Kim, M.D., Jin-Hyeok Hwang, M.D., Young Soo Park, M.D., Sang-Hyub Lee, M.D.
Clin Mol Hepatol. 2010;16(1):57-65.   Published online March 26, 2010
View: 4567   Download: 27  Citations: 8
Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients
Myoung Hee Lee , Sun Gyo Lim , Su Jin Jeon , Chang Joon Kang , Young Ju Cho , Soon Sun Kim , Da Mi Lee , Jae Youn Cheong , Sung Won Cho
Clin Mol Hepatol. 2009;15(4):446-453.   Published online December 31, 2009
View: 3799   Download: 27  Citations: 4
Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea
Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D., Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.
Clin Mol Hepatol. 2009;15(1):25-41.   Published online March 31, 2009
View: 4423   Download: 50  Citations: 3
1 | 2 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 767
TOTAL : 1040084
Close layer